Collectively, limited data support that hepatic OPG may favor hepatic steatosis, NASH, and fibrosis, while hepatic RANKL upregulation may be related to persistent hepatic inflammation and hepatocellular injury. The gene discussed is TNFRSF11B; the disease is metabolic dysfunction-associated steatohepatitis.